Does atomoxetine boost motivation in healthy adults?
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether atomoxetine, a medication that affects brain chemicals, can boost motivation in healthy adults. If you join, you'll be helping researchers understand the drug's effects and whether it might help with conditions that affect motivation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are in good physical health.
- You can give informed consent and understand English well enough to complete study tasks.
- You do not have a serious mental health condition, heart problems, high blood pressure, or other significant medical conditions.
- You are not taking certain medications (e.g., for the brain, heart, or blood pressure).
- For women: you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a common antidepressant (escitalopram) affects motivation and effort in healthy adults. It uses brain scans and tasks to understand the medication's effects.
This study tests a digital therapy to improve apathy (feeling unmotivated or “checked out”) in people age 60+ who have depression. It also uses brain imaging (MRI) and questionnaires to see whether the treatment helps brain function linked to motivation.
This study tests if combining a type of brain stimulation (repetitive TMS) with a medication (methylphenidate, commonly used for ADHD) can improve apathy in people with dementia. If you have Alzheimer's or mixed dementia and struggle with low motivation, this trial may help you.
This study tests whether a treatment (atomoxetine or metformin) can help people with Alzheimer's disease maintain an improved state for at least 18 months. It may help you or a loved one stabilize symptoms and slow disease progression.
This trial tests a noninvasive brain stimulation treatment (called rTMS) to help people who have had ongoing apathy (lack of motivation/interest) for at least a month. You might benefit if your apathy is persistent, your other symptoms are stable, and you meet the safety and medication rules.
This study tests whether a very low dose of a medication called atomoxetine, which affects a brain chemical called noradrenaline, can help with how people learn. It is for right-handed adults who are generally healthy and not taking other medications.
Hear when a new Apathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.